Application of Proteomics Tools in Breast Cancer Research | Biomarker Discovery for Diagnosis and Prognosis

Priyanka Maurya (u. a.)

ISBN 10: 384841001X / ISBN 13: 9783848410019

Published by LAP LAMBERT Academic Publishing, 2012

About this Item

Application of Proteomics Tools in Breast Cancer Research | Biomarker Discovery for Diagnosis and Prognosis | Priyanka Maurya (u. a.) | Taschenbuch | 120 S. | Englisch | 2012 | LAP LAMBERT Academic Publishing | EAN 9783848410019 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.

Seller Inventory # 106602292

Bibliographic Details

• Title: Application of Proteomics Tools in Breast Cancer Research | Biomarker Discovery for Diagnosis and Prognosis
• Publisher: LAP LAMBERT Academic Publishing
• Publication Date: 2012
• Language: English
• ISBN 10: 384841001X
• ISBN 13: 9783848410019
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 220W x 150H x 8D millimeters 220 millimeters width by 150 millimeters height by 8 millimeters depth
• Weight: 197 grams
• Seller catalogs:
  • Bücher

About this title

Synopsis

Breast cancer is the second leading cause of cancer deaths and is the most common cancer among women. Although a number of biomarkers are being used in clinical practice, significant number cases for breast cancers are detected late and difficult to treat. Therefore, new biomarkers are in need to improve diagnosis and the therapeutics for breast cancer. The emergence of proteomics technologies has facilitated researcher comprehensive differential expression analyses of proteins in healthy and cancer individuals. The most commonly used proteomic techniques in breast cancer research are 2D-PAGE, SELDI-ToF MS, Protein Arrays, ICAT, iTRAQ and SILAC. Recent advancement in proteomics has also enabled to study the intracellular signalling pathways that may underlie the development of breast cancer. Thus, proteomics could play significant roles in identification of novel biomarkers and/or drug targets to improve existing prognosis and diagnosis of breast cancer. This book covers a selection of advances in the realm of proteomics and its promise for the discovery of biomarkers and drug targets, and sample preparation of cell culture and clinical martial for breast cancer research.

About the Author

I did my PhD in Biotechnology from National Institute for Cellular Biotechnology, DCU, Ireland and currently, working as Post-Doctoral Researcher at Institute of Applied Microbiology, BOKU, Vienna. I have been working in field of proteomics and cancer research since last seven years.